文献速递眼整形与眼眶眼底病与葡萄膜炎

甲状腺相关眼病不同脂肪库来源脂肪干细胞特性差异

Depot-specific characteristics of adipose tissue-derived stromal cells in thyroid-associated orbitopathy.
PubMed 文献 · Br J Ophthalmol · 2018-04-17

本研究比较了3例甲状腺相关眼病患者眼睑、眼眶及腹部三个脂肪库来源的脂肪组织来源干细胞(ADSCs)的间充质、肌纤维生成及脂肪生成特性与透明质酸合成。结果显示各库ADSCs间充质标志物表达相似,但眼睑和眼眶ADSCs诱导后脂联素与HAS-2 mRNA显著高于皮下ADSCs,肌纤维生成也显著更多。作者认为这些脂肪库特异性特征可能促进TAO的部位特异性脂肪组织受累。

要点

  • 3例TAO患者眼睑、眼眶及腹部ADSCs间充质标志物CD44、CD90、CD105表达无显著差异。
  • 诱导后眼睑和眼眶ADSCs脂联素与HAS-2 mRNA显著高于皮下ADSCs。
  • 肌纤维生成诱导后眼眶和眼睑ADSCs肌成纤维细胞比例及α-SMA mRNA显著高于皮下ADSCs。

核心结论

  • 同一供者不同脂肪库ADSCs间充质表型相似,但脂肪生成、肌纤维生成潜力及相关透明质酸合成存在显著差异。
  • 这些脂肪库特异性特征可能促进TAO的部位特异性脂肪组织受累。

研究设计与样本

  • 从3例甲状腺相关眼病患者的眼睑、眼眶和腹部脂肪组织生成ADSCs。
  • 用逆转录PCR和免疫荧光染色鉴定间充质标志物。
  • 进行3周脂肪生成诱导,用尼罗红染色及PPARγ、脂联素、HAS-2的qPCR评估。
  • 进行7天肌纤维生成诱导,用免疫荧光染色及α-SMA的qPCR检测。

主要发现

  • 各库ADSCs间充质标志物CD44、CD90、CD105表达水平相似(p=0.288、p=0.43、p=0.837)。
  • 脂肪生成诱导后,三个库细胞内脂质均增加超过32%,PPARγ mRNA均增加超过两倍。
  • 诱导后眼睑和眼眶ADSCs脂联素mRNA分别为2.4×10^7、3.9×10^6倍,皮下ADSCs低于检测限。
  • 诱导后眼睑和眼眶ADSCs HAS-2 mRNA分别为63.3倍、26.1倍,皮下ADSCs为33%降低(均p=0.002)。
  • 肌纤维生成诱导后眼眶、眼睑、皮下ADSCs肌成纤维细胞比例分别为80.2%、70.6%、29.3%,α-SMA mRNA分别为30.2倍、24.2倍、1.7倍(均p=0.002)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Thyroid-associated orbitopathy (TAO) causes inflammatory fibroproliferation of periocular connective tissues. We compared adipose tissue-derived stem/stromal cells (ADSCs) from three adipose depots of each patient with TAO on mesenchymal, myofibrogenic, adipogenic properties and associated hyaluronan (HA) synthesis. METHODS: ADSCs were generated from periocular (eyelid, orbital) and subcutaneous (abdominal) adipose tissues of three patients with TAO. Mesenchymal markers were characterised by reverse transcription-PCR and immunofluorescent staining. A 3-week adipogenic induction was evaluated by Nile red staining and quantitative PCR (qPCR) of peroxisome proliferator-activated receptor (PPARγ), adiponectin and hyaluronan synthase (HAS)-2. A 7-day myofibrogenic induction was assayed by immunofluorescent staining and qPCR of α-smooth muscle actin (α-SMA). RESULTS: ADSCs from all depots expressed similar levels of mesenchymal markers CD44, CD90 and CD105 (p=0.288, p=0.43 and p=0.837, respectively). After adipogenic induction, intracellular lipid increased for more than 32% and PPARγ mRNA showed more than twofold increase from all three depots. However, adiponectin and HAS-2 mRNA levels were significantly higher in the eyelid and orbital ADSCs than those from the subcutaneous ADSCs after induction (2.4×107, 3.9×106 folds vs below detection limit; 63.3-fold, 26.1-fold, vs 33% reduction, respectively; all p=0.002). Significantly more myofibroblasts and higher mRNA level of α-SMA were obtained from the orbital and eyelid compared with the subcutaneous ADSCs during myofibrogenic induction (80.2%, 70.6% vs 29.3%; 30.2-fold, 24.2-fold vs 1.7-fold, respectively; all p=0.002). CONCLUSION: ADSCs from different adipose depots of the same donors exhibited similar mesenchymal phenotypes but differed significantly in adipogenic, myofibrogenic potentials and associated HA synthesis. These depot-specific characteristics of ADSCs may contribute to site-specific adipose tissue involvement in TAO.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Wong JSC, Chu WK, Li BF, et al. Depot-specific characteristics of adipose tissue-derived stromal cells in thyroid-associated orbitopathy. Br J Ophthalmol. 2018. PMID: 29666119. doi:10.1136/bjophthalmol-2017-311339

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。